1260 related articles for article (PubMed ID: 32843638)
1. The updated landscape of tumor microenvironment and drug repurposing.
Jin MZ; Jin WL
Signal Transduct Target Ther; 2020 Aug; 5(1):166. PubMed ID: 32843638
[TBL] [Abstract][Full Text] [Related]
2. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
3. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
Muntimadugu E; Kommineni N; Khan W
Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
[TBL] [Abstract][Full Text] [Related]
5. Neurotransmitters: promising immune modulators in the tumor microenvironment.
Xiao L; Li X; Fang C; Yu J; Chen T
Front Immunol; 2023; 14():1118637. PubMed ID: 37215113
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
Deepak KGK; Vempati R; Nagaraju GP; Dasari VR; S N; Rao DN; Malla RR
Pharmacol Res; 2020 Mar; 153():104683. PubMed ID: 32050092
[TBL] [Abstract][Full Text] [Related]
7. Possible Role of Metformin as an Immune Modulator in the Tumor Microenvironment of Ovarian Cancer.
Tsogas FK; Majerczyk D; Hart PC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467127
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
Li M; Zhang F; Su Y; Zhou J; Wang W
Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
[TBL] [Abstract][Full Text] [Related]
9. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
[TBL] [Abstract][Full Text] [Related]
10. Complex interplay between tumor microenvironment and cancer therapy.
Shen M; Kang Y
Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
[TBL] [Abstract][Full Text] [Related]
11. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
[TBL] [Abstract][Full Text] [Related]
12. Repurposing Vitamin C for Cancer Treatment: Focus on Targeting the Tumor Microenvironment.
Li WN; Zhang SJ; Feng JQ; Jin WL
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681589
[TBL] [Abstract][Full Text] [Related]
13. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.
Deep G; Agarwal R
Curr Cancer Drug Targets; 2013 Jun; 13(5):486-99. PubMed ID: 23617249
[TBL] [Abstract][Full Text] [Related]
15. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
Pitt JM; Marabelle A; Eggermont A; Soria JC; Kroemer G; Zitvogel L
Ann Oncol; 2016 Aug; 27(8):1482-92. PubMed ID: 27069014
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
17. Tumor hypoxia: From basic knowledge to therapeutic implications.
Liao C; Liu X; Zhang C; Zhang Q
Semin Cancer Biol; 2023 Jan; 88():172-186. PubMed ID: 36603793
[TBL] [Abstract][Full Text] [Related]
18. Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance.
Tajaldini M; Poorkhani A; Amiriani T; Amiriani A; Javid H; Aref P; Ahmadi F; Sadani S; Khori V
Eur J Pharmacol; 2023 Oct; 957():175991. PubMed ID: 37619785
[TBL] [Abstract][Full Text] [Related]
19. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
[TBL] [Abstract][Full Text] [Related]
20. Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance.
Weng CY; Kao CX; Chang TS; Huang YH
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33514004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
